Related by context. All words. (Click for frequent words.) 75 candidate REP# 73 TELINTRA R 73 Initiates Phase II 73 XL# anticancer compounds 73 Completes Patient Enrollment 72 Personalized Immunotherapy 72 Initiates Enrollment 72 highly purified pasteurized 72 Iluvien ® 71 Therapeutic Competitors companiesandmarkets.com adEgemonye 71 KRYSTEXXA TM 71 Receives Approvable Letter 71 Files IND 71 non nucleoside inhibitor 71 Kosan dependence 71 Begins Dosing 71 Xcytrin R 71 Files Investigational 70 candidate AQ4N 70 Submits Biologics License Application 70 PDX pralatrexate 70 Idera Pharmaceuticals 70 Initiates Phase III 70 SinuNase ™ 70 markets HP Acthar 70 Therapeutic Competitors Companies 69 MOVIPREP R 69 mesylate tablets approved 69 IMPDH inhibitor 69 delivers fluocinolone acetonide FA 69 Receives Orphan Drug 69 OMRIX Biopharmaceuticals Inc. 69 RANK Ligand inhibitor 69 Submits Response 69 developing Zerenex ferric 69 PROVENGE ® 69 JZP 69 candidate deforolimus 69 R sorafenib tablets 69 FOLOTYN ® 69 SPL# Gel vaginal microbicide 69 Announces Tentative Approval 69 AAG geldanamycin analog 69 R MSCRAMM 69 proprietary intranasal insulin 69 BRILINTA 69 Inc. Nasdaq VVUS 69 Corp. www.anavex.com 69 Inc. www.micromet inc.com 69 Presents Preclinical 68 Initiates Clinical Trial 68 GVAX ® 68 virus HCV protease inhibitor 68 Granted Orphan Drug 68 Tibotec BVBA 68 Initiates Clinical 68 subsidiaries visit http:/www.apricusbio.com 68 zolpidem tartrate sublingual tablet 68 LymphoStat B TM 68 OMRIX Biopharmaceuticals 68 novel MetAP 2 68 Biologic License Application BLA 68 MKC# MT 68 intranasal insulin product 68 FACTIVE R gemifloxacin 68 Zemiva TM 68 include Phenoptin TM 68 IG HCR ;) CO 68 Tezampanel 68 Presents Positive 68 Roche OTC RHHBY 68 Submits NDA 68 ALN PCS 68 successfully commercialize Iluvien 68 TSX VENTURE DMA 68 developing ostarine selective 68 proprietary intravenous formulation 68 GVAX R 68 molecular imaging radiopharmaceutical 68 polysaccharide polymer 67 Initiates Phase 2b 67 Submits IND 67 Telik logo TELINTRA 67 Silenor ® doxepin 67 Nasdaq IDIX 67 NYSE Amex PTN 67 Nasdaq CYCC Nasdaq CYCCP 67 Soliris TM eculizumab 67 markets Testim ® 67 Anturol ® 67 Solazed TM 67 Empatic ™ 67 Nasdaq NPSP announced 67 Initiate Clinical Trial 67 Receives Fast Track 67 Pegloticase 67 Nasdaq VRTX 67 SinuNase TM 67 NASDAQ MNKD focuses 67 initiated Phase Ib 67 pralatrexate injection folate analogue 67 BiovaxID TM 67 please visit www.medicinova.com 67 PNP inhibitor 67 Nasdaq HALO 67 sapropterin dihydrochloride Phase 67 MAb therapy 67 BiTE R 67 topical antifungal product 67 Nabi HB Intravenous 67 Transcept Pharmaceuticals 67 Receives Orphan Drug Designation 67 Inc. Nasdaq OXGN 67 Announces Poster Presentations 67 please visit http:/www.vandapharma.com 67 Ostarine ™ 67 Presents Preclinical Data 67 Sunesis Pharmaceuticals 67 faropenem medoxomil 67 Intermezzo ® zolpidem tartrate 67 sitaxsentan sodium 67 Chemokine Therapeutics 67 Zenvia ™ 67 BioSante Pharmaceuticals Announces 67 Vitrasert R 67 refractory chronic lymphocytic 67 GTC NASDAQ GTCB 67 thrombin component 67 HEPLISAV ™ 67 PANVAC VF 67 Nasdaq IDIX biopharmaceutical 67 Crofelemer budesonide foam 67 Nasdaq HALO biopharmaceutical 67 Sphingomab TM 67 Inc. Nasdaq IMGN 67 Inc. NASDAQ ZLCS 67 JOULFERON 67 NASDAQ BDSI 67 Cellegy Pharmaceuticals 67 ILUVIEN ® 67 Nicotine Conjugate Vaccine 66 PRAECIS PHARMACEUTICALS INCORPORATED 66 FDA Accepts 66 Commences Phase 66 sNDAs 66 LibiGel ® 66 ENZON 66 TRACON Pharmaceuticals 66 Submits Investigational 66 Hematide ™ peginesatide 66 Nasdaq TARG 66 oral prodrug 66 TBC# 66 orBec ® oral beclomethasone 66 DIFICID ™ 66 Neo Kidney Augment 66 Inc NGSX 66 www.ucb group.com 66 novel trazodone formulation 66 By JAMAAL ABDUL 66 targeted radiotherapeutic 66 methylnaltrexone bromide 66 candidate XP# 66 dextromethorphan quinidine 66 visit www.targanta.com 66 dimebon latrepirdine 66 lead molecular radiotherapeutic 66 ELADUR TM 66 Altus Pharmaceuticals 66 Acetavance TM 66 Initiates Dosing 66 Receive Milestone Payment 66 Nasdaq PARD 66 Somatuline Depot 66 Inc. OTCBB ALRX 66 Empatic TM 66 midstage clinical 66 Receives Milestone Payment 66 StaphVAX R 66 NASDAQ INSM 66 Meets Primary Endpoint 66 LibiGel ® testosterone gel 66 Inc. NASDAQ IDIX 66 overactive bladder AA# 66 Successfully Completes Phase 66 corticotropin injection 66 Spiegelmer ® 66 Panzem R 66 novel L DOS# 66 LEVADEX TM 66 BEMA Granisetron 66 intravenous acetaminophen 66 Phase #b/#a clinical 66 BENLYSTA ® 66 Initiate Phase 66 using VIAdel TM 66 Oracea TM 66 Nasdaq ACHN 66 LymphoStat B belimumab 66 Qutenza TM 66 anti botulism antibody 66 pharmacogenomic translational research 66 Nasdaq DVAX 66 selective estrogen receptor modulator 66 GATTEX TM 66 Archexin 66 Inc Therapeutic Competitors 66 novel synthetic PEGylated 66 Romidepsin 66 OMAPRO ™ 66 AMEX ISV 66 Achieves Primary Endpoint 66 Nasdaq THLD 66 Omigard TM 66 MEDAREX 66 Kuvan TM sapropterin 66 sterile lidocaine patch 66 Cutanea Life Sciences 66 XIAFLEX ® 66 LibiGel transdermal testosterone gel 66 motexafin gadolinium Injection 66 Albugon 66 TSX RVX 66 XL# XL# XL# XL# 66 PAION AG ISIN 66 CRMD# 66 Hematide ™ 66 lintuzumab SGN 66 SPRYCEL ® 66 REG1 Anticoagulation System 66 apricitabine ATC 66 Amigal TM 66 phase III isavuconazole 66 Completes Enrollment 66 Inc. Nasdaq INSM 66 SYCREST 66 Asentar TM 66 Maxy G# 66 Modrenal R 66 visit www.sciclone.com 65 Crucell NV NYSE Euronext 65 PrevOnco 65 NASDAQ ABII 65 Veronate R 65 adecatumumab MT# 65 Initiates Clinical Trials 65 Inc. NASDAQ OXGN 65 CYCLOSET ® 65 TRISENOX R 65 Submits Supplemental 65 Civacir 65 Nasdaq PGNX today 65 Targanta Therapeutics Corporation 65 CombinatoRx Incorporated 65 semi synthetic lipoglycopeptide 65 Nasdaq VNDA 65 novel therapeutic antibodies 65 Nasdaq ENMD 65 Nasdaq XTLB 65 Troxatyl TM 65 JAK2 Inhibitor 65 VitiGam 65 OTCBB DORB 65 PF # [002] 65 Rhucin ® recombinant 65 ALTROPANE R 65 RDYN 65 NASDAQ VPHM 65 http:/www.sunesis.com 65 Glufosfamide 65 symbol AVXL 65 Alzhemed TM 65 www.palatin.com 65 autologous cellular immunotherapy 65 Genaera Corporation 65 Uvidem 65 product platforms AZX# 65 granted Ortec 65 Nasdaq VRTX today 65 nanofiltered plasma derived 65 DPX Survivac 65 hyaluronidase enzyme 65 Trofex ™ 65 Pruvel ™ prulifloxacin 65 COLAZAL R 65 Dyax logo 65 Akesis Pharmaceuticals 65 leading oral taxane 65 OvaRex R 65 Allovectin 7 65 Nasdaq EPCT 65 GENR 65 Receives Tentative Approval 65 VIVITROL ® 65 www.ucb.com 65 rasagiline tablets 65 mertansine 65 Prednisporin TM 65 Nasdaq MNKD focuses 65 TSX CTI 65 John F. Thero 65 Amicus Therapeutics Nasdaq FOLD 65 NYSE Amex HEB 65 Onalta ™ 65 mitogen activated ERK kinase 65 NASDAQ ADLR 65 Auxilium transmucosal film 65 vosaroxin 65 modified glutathione analog 65 Therapeutic Competitors 65 IV APAP 65 Combination REOLYSIN R 65 OTC BB PVCT http:/www.pvct.com 65 Somatuline R Autogel R 65 OTCBB PYTO 65 HP Acthar Gel repository 65 MSCRAMM ® 65 Luveris R Ovidrel R 65 Prednisporin 65 NASDAQ SNTA 65 LEVADEX ™ 65 www.vivus.com 65 investigational pharmacologically unique 65 investigational humanized monoclonal antibody 65 OTCBB UGNE http:/www.unigene.com 65 Hybridon 65 NASDAQ IDEV 65 please visit www.middlebrookpharma.com 65 nasal calcitonin product 65 Inc. NASDAQ ORXE 65 Anidulafungin 65 Staphylococcus aureus Immune Globulin 65 hypoxia activated prodrug 65 TSX VENTURE GAP 65 proprietary Capillary Aerosolization Technology 65 Zemiva TM Trofex TM 65 HuMax TAC 65 OTCQB CTIX 65 Hedgehog Pathway Inhibitor 65 Arno Therapeutics 65 GATTEX ® 65 Difimicin 65 Ohr Pharmaceutical Inc. 65 Harbor BioSciences 65 Aradigm Logo 65 2 methoxyestradiol 65 Aganocide ® 65 DARA logo 65 Trofex TM 65 Inc. Nasdaq SUPG 65 dacetuzumab SGN 65 NASDAQ AVNR 65 BNVI 65 infectious diseases autoimmune 65 Ceplene TM 65 KAI Pharmaceuticals 64 hoFH 64 evaluating bafetinib 64 MBRX 64 rHuPH# recombinant human 64 PSDV 64 GLOBE NEWSWIRE Cyclacel Pharmaceuticals 64 Catalyst Biosciences 64 AMEX RGN 64 Levoleucovorin 64 Pruvel TM 64 QNEXA ® 64 Surfaxin LS 64 Reports Preclinical Data 64 Nasdaq ALTH 64 Inc. AMEX YMI 64 proprietary HuCNS SC 64 Ambrisentan 64 pentadentate logo R 64 label Lipofen R 64 DVAX 64 Æterna Zentaris Inc. 64 OTC BB PVCT 64 HEPLISAV TM 64 R bortezomib 64 THR beta agonist 64 Patient Enrollment 64 Announces Dosing 64 oral salmon calcitonin 64 4SC AG ISIN DE# 64 Nasdaq SLXP 64 ONSOLIS TM 64 Dendreon investigational 64 TRANSDUR ® 64 orally administered inhibitor 64 TRANSDUR ™ 64 candidate SILENOR TM 64 TM Aganocide 64 Vion Pharmaceuticals 64 BioGlue ® 64 product candidate Lpathomab 64 Pivotal Phase III 64 novel histone deacetylase 64 Risperidone Oral Solution 64 developing ACAPODENE 64 Meritage Pharma 64 NASDAQ SCMP 64 Nasdaq CYCC 64 Pafuramidine 64 NASDAQ TARG 64 TRIOLEX HE# APOPTONE HE# 64 ADVENTRX Pharmaceuticals 64 Liprotamase 64 Announce License Agreement 64 Exelixis logo 64 please visit http:/www.atherogenics.com 64 IL# PE#QQR 64 ionotropic glutamate receptor antagonists 64 personalized dendritic 64 diabetes irritable bowel 64 VYVANSE TM lisdexamfetamine 64 NASDAQ PCYC 64 Metabasis Therapeutics 64 Etubics 64 Nasdaq IMGN 64 Inc. NASDAQ IDMI 64 Feraheme ® 64 Bicifadine 64 Inc. NASDAQ SNUS 64 rALLy clinical trial 64 NasdaqGM NTEC today 64 Plicera 64 HepeX B 64 Nasdaq UNIS 64 oral ghrelin agonist 64 ASE SVA 64 PEG PAL PEGylated recombinant 64 Nasdaq MITI 64 Inc. Nasdaq AVRX 64 Adamis Pharmaceuticals 64 Palatin Technologies Inc. 64 Cardium Therapeutics TM 64 MKC# MKC# PP 64 NASDAQ OSCI 64 signal detection CTSD 64 OTCBB GNTA 64 First Patient Enrolled 64 OTCBB NNVC 64 peptidic compound 64 Exherin 64 omacetaxine mepesuccinate 64 Nasdaq CLDX 64 Pruvel ™ 64 valopicitabine NM# 64 please visit http:/www.sunesis.com 64 alvespimycin 64 Inc. ProMetic www.prometic.com 64 Nasdaq BDSI 64 orBec R oral beclomethasone 64 candidate MyVax 64 investigational pan BCR 64 P. Luci 64 tiapamil 64 Orapred ODT 64 http:/www.unigene.com 64 Inc. NASDAQ ICGN 64 Initiates Phase 64 allosteric modulator PAM 64 Investigational Compound 64 phenylalanine ammonia lyase 64 please visit www.dyax.com 64 ATPace TM 64 vapreotide acetate 64 trastuzumab DM1 T DM1 64 acetylgalactosamine 6 64 Tyzeka Sebivo 64 FUSILEV ® 64 Oral Calcitonin 64 compound KOS 64 Craig Tooman 64 novel orally inhaled 64 P#X# antagonist 64 NASDAQ ENMD 64 NUEDEXTA ™ 64 Phase Ib IIa 64 PRN FDA Approves 64 Inc. Nasdaq IDMI 64 website www.celsion.com 64 migraine headaches neuropathic pain 64 XL# XL# 64 candidates Azedra TM 64 balsalazide tablet 64 LSE SHP.L 64 Hematide TM 64 Regeneron Pharma 64 WeissComm Partners +#-#-#-# 64 mild vasodilator 64 Civacir TM Hepatitis C 64 AlgoRx 64 Trubion Pharmaceuticals TRBN 64 Myrexis Inc. 64 EPIX Pharmaceuticals 64 www.transcept.com 64 Troxatyl 64 TOCOSOL Camptothecin 64 Pruvel 64 ENABLE Phase 2 64 oxybutynin ATD TM 64 Cloretazine ® 64 Nasdaq IDRA today 64 RNA interference RNAi therapeutics 64 Augment TM 64 Valtropin 64 intranasal formulation 64 Emezine 64 Nasdaq GENR 64 platform HDL Mimetic 64 NASDAQ KERX 64 Unit Dose Budesonide 64 Phase 2b Clinical Trial 64 Inc. Nasdaq TNGN 64 mGluR2 positive 64 Cinryze ™ 64 Georges Gemayel 64 Daclizumab 64 Ferumoxytol 64 pan histone deacetylase 64 Inc. Nasdaq CRTX 64 Corp. Nasdaq BSTC 64 Prestara TM 64 forodesine hydrochloride 64 Vicriviroc 64 Inc. NASDAQ VSGN 64 HepeX B TM 64 Cetrorelix 64 programs visit http:/www.bionovo.com 64 Phase III Pivotal 64 BioSpecifics Technologies Corp. 64 OTCBB URGP specialty 64 Aganocide 64 visit http:/www.mannkindcorp.com 64 Nasdaq DYAX 64 Nasdaq SVNT 64 non nucleoside polymerase 63 Investigational Oral 63 Vitamin D analogue 63 M# rationally 63 Naglazyme R 63 CAMPATH R 63 Amex PTN 63 Alvine Pharmaceuticals 63 ThermoDox ® clinical 63 ABL inhibitor 63 topical non steroidal 63 RH1 targeted chemotherapeutic agent 63 Circ Pharma 63 Junovan TM 63 KRYSTEXXA ™ 63 Corp. ADLR 63 ZALBIN 63 NLTX 63 Completes Patient Enrolment 63 NASDAQ NOVN today 63 PROLOR Biotech Inc. 63 Trastuzumab DM1 63 Carl Spana Ph.D. 63 http:/www.nabi.com 63 Nasdaq OPTR 63 novel emulsion formulation 63 Application BLA 63 Transkaryotic Therapies TKTX 63 INTEGRILIN R eptifibatide Injection 63 ocular formulation 63 OTCBB CVBT 63 valtorcitabine 63 Phase III Clinical Trial 63 OTC IPXL 63 CB2 selective receptor agonist 63 BioSante Pharmaceuticals NASDAQ BPAX 63 toenail onychomycosis 63 Angiocept 63 TapImmune Inc. 63 Alnylam Nasdaq ALNY 63 initiated Phase 1b 63 NASDAQ NPSP 63 including eniluracil ADH 63 CardioVascular BioTherapeutics Inc. 63 therefore therapeutically equivalent 63 NRGN 63 NASDAQ CORT 63 mGluR5 negative 63 NU# direct 63 Polymer Microspheres 63 Nasdaq AGEN 63 ACEON R perindopril erbumine 63 Louis Drapeau 63 topically applied SEPA 63 investigational antiplatelet agent 63 molecular therapeutics immunotherapies 63 ELADUR ™ 63 Gentamicin Surgical Implant 63 Phusion Laboratories 63 Inc. OTCBB BCLI 63 Adenosine Therapeutics 63 Nasdaq ACOR 63 ASX PGL 63 NASDAQ INGN 63 ARYX 63 histamine dihydrochloride 63 DP VPA 63 Alnylam #x# 63 Mylan Receives Approval 63 Initiate Phase III 63 Generx TM 63 evaluating satraplatin 63 Phase IIb Trial 63 Fx #A 63 QuantRx Biomedical Corporation 63 Thallion Pharmaceuticals 63 Nasdaq ONXX 63 Anturol TM 63 NYSE Amex RNN 63 Nasdaq AVNC 63 Oxis International 63 Nycomed GmbH 63 liver resection surgeries 63 AMEX ONI 63 Namenda Memantine HCl 63 OTCBB QTXB 63 AMEX AOM 63 ImmuCell Corporation 63 LibiGel testosterone gel 63 candidate ATHX 63 Capstone Therapeutics 63 Aflibercept 63 TELINTRA 63 Evoltra ® 63 Febuxostat 63 treat chronic sinusitis 63 HCV RNA polymerase 63 fibrosis IPF 63 defensin mimetic antibiotic 63 Dyloject TM 63 Ereska 63 Licenses Novel 63 NGSX 63 Inc. Nasdaq MITI 63 TNFerade ™ 63 Onyx Pharmaceuticals Announces 63 NovaBay Pharmaceuticals Inc. 63 Nasdaq KERX 63 Inc. NASDAQ XNPT 63 acetonide FA 63 Nasdaq MNKD focused 63 developing Zerenex TM 63 NASDAQ NRGN 63 MAGE A3 ASCI 63 Barrier Therapeutics Inc. 63 TRX1 63 NASDAQ RNAI 63 oral picoplatin 63 oxandrolone USP 63 NASDAQ OPTR 63 oral beclomethasone dipropionate 63 Inc. dba Vitro 63 Nasdaq IDRA 63 Maribavir 63 Immune Globulin Human 63 Metabasis Therapeutics Inc. 63 Kuvan R 63 Predictive medicine 63 SILENOR 63 humanized interleukin 6 63 UGNE 63 sNDA submission 63 testosterone gel LibiGel 63 Perflubutane Polymer Microspheres 63 CCR5 mAb 63 miconazole Lauriad 63 DOV Pharmaceutical Inc. 63 Present Preclinical Data 63 Regains NASDAQ 63 Nasdaq PGNX 63 Nasdaq ANDS 63 About Chemokine Therapeutics 63 includes TOLAMBA TM 63 transthyretin mediated amyloidosis ATTR 63 Biological License Application 63 NASDAQ DRRX 63 Nasdaq AVNR 63 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 63 TAFA# 63 Ondansetron Injection 63 biomimetics non 63 Romiplostim 63 oral methylnaltrexone 63 Tramiprosate ALZHEMED TM 63 markets COLAZAL 63 Hsp# Inhibitor 63 OTCBB INSV 63 ZEVALIN ® 63 non porcine pancreatic 63 telomerase inhibitor drug 63 Vaccine Adjuvant 63 R PEG uricase 63 OvaRex ® MAb 63 www.exelixis.com 63 romidepsin novel 63 personalized cellular immunotherapy 63 Inc. Nasdaq RDYN 63 severe hypercholesterolemia 63 acyclovir Lauriad R 63 treats acute lymphoblastic 63 NASDAQ SVNT 63 Inc. NASDAQ MRNA 63 oncolytic virus therapies 63 IgG1 monoclonal antibody 63 Inc. Nasdaq IDIX 63 NASDAQ FLML 63 Nanobody R 63 NASDAQ VRTX 63 INSPIRE Trial Phase III 63 humanized therapeutic 63 dasatinib Sprycel ® 63 Phase III multicenter 63 Aphton Corporation 63 Velac 63 AzaSite TM 63 Ceflatonin R 63 Bradmer Pharmaceuticals 63 commercializing Loramyc ® 63 R sipuleucel T 63 SynthRx 63 http:/www.viropharma.com 63 technology visit http:/www.genmab.com 63 muscarinic receptor agonist 63 ASONEP ™ 63 NASDAQ CYTK announced 63 Entereg alvimopan 63 Veronate 63 Prodarsan R 63 CYT# vascular disrupting 63 VEGFR2 inhibitor 63 novel VDA molecule 63 Inc. Nasdaq ANSV 63 Marketing Authorisation Application 63 Transdel Pharmaceuticals Inc. 63 ALN VSP Phase 63 TKB# 63 REMOXY NDA 63 OrthoLogic Corp. 63 NasdaqGM SPPI 63 XL# XL# XL# 63 anti VEGF aptamer 63 NASDAQ DYAX 63 Inc. Nasdaq MDVN 63 Apricus Biosciences 63 Inc. NASDAQ AEZS 63 ATRA IV 63 CORLUX CORT # 63 Oral NKTR 63 NASDAQ AEZS 63 allosteric modulator NAM 63 ® bortezomib 63 REMOXY POSIDUR ELADUR 63 BTG plc 63 Alfacell proprietary ribonuclease 63 diarrhea predominant irritable 63 Inc. NASDAQ HEPH 63 compound INCB# 63 Auxilium Pharma 63 Orphan Drug designations 63 Nasdaq ADLR 63 Fibrillex TM 63 Ore Pharmaceuticals 63 NASDAQ CRXL SWISS CRX 63 FDA APPROVES 62 www.cellgenesys.com 62 OTCBB HNAB 62 Accentia Biopharmaceuticals 62 please visit www.cpexpharm.com 62 Chimigen TM 62 SUTENT ® 62 Nasdaq SCLN 62 please visit www.sucampo.com 62 Phase lll 62 Nasdaq AEGR 62 negative allosteric modulator 62 NASDAQ ALTH 62 GLP1 INT TM 62 Phase IIb III 62 Nasdaq PARS 62 antibiotic candidate Ramoplanin 62 Exalgo ™ 62 Enzon Pharmaceuticals Inc 62 dihydrochloride Tablets 62 commercialize becocalcidiol patented 62 Invites Investors 62 PDUFA Date 62 Aztreonam 62 Nasdaq NPSP 62 Nasdaq ACAD 62 sapropterin dihydrochloride 62 www.bioenvision.com 62 ELND-#/AZD-# 62 Dynepo TM 62 Aegerion 62 Fodosine 62 molecular chaperone regulation 62 NTII 62 TSX VENTURE IMV 62 proprietary capillary aerosolization 62 EnzymeRx 62 PEG irinotecan 62 Multiple Ascending Dose 62 CancerVax Corporation 62 PAION AG 62 Nasdaq AFFY today 62 developing Surfactant Replacement 62 Inc. www.prometic.com 62 PNT# 62 Juergen Engel Ph.D. 62 anti CD3 monoclonal 62 ® decitabine 62 NYSE Amex PBTH 62 lucinactant 62 Genentech sanofi aventis 62 Through Glycoscience R 62 Company website www.anormed.com 62 REG2 Regado 62 ALN TTR 62 Neo Urinary Conduit 62 selective immunoproteasome inhibitor 62 NASDAQ CLSN 62 LibiGel NDA 62 tramiprosate Alzhemed TM 62 Pirfenidone 62 EVIZON ™ 62 PDE4 inhibitor 62 Arzerra TM 62 UCB www.ucb group.com 62 Inc EXEL 62 Nasulin ™ 62 http:/www.pharmacopeia.com 62 addressing idiopathic pulmonary 62 see www.virexx.com 62 NASDAQ ACOR 62 BioGlue R 62 DRRX 62 Nasdaq FOLD 62 ALN TTR# 62 Inc. NASDAQ AGIX 62 AMITIZA ® 62 Harry Palmin President 62 KRN# 62 Phase III Trial 62 Cyclacel Pharmaceuticals 62 immunosuppressive compound 62 PLK1 SNALP 62 Nasdaq RDEA 62 Nasdaq ZIOP 62 BLA filing 62 concerning CombinatoRx 62 Matrix Phase 2b 62 Enrolls First 62 TransVax tm 62 Inc. NASDAQ AXYX 62 MKC# 62 Germany FSE SCH 62 TSX VIR 62 Augment ™ 62 ZYBRESTAT fosbretabulin 62 OTC BB EMIS 62 CeNeRx BioPharma 62 Peyronie disease Frozen Shoulder 62 Panzem R NCD 62 http:/www.vivus.com 62 generation DACH Platinum 62 delivery polymer matrix 62 Nasdaq CTIC 62 Actelion Ltd 62 Amira Pharmaceuticals 62 BPAX 62 Sinobiomed Inc. 62 CRMD pharmaceutical 62 ZFP Therapeutics 62 OTCBB AFLB 62 Annamycin 62 Salmedix 62 Inc. NASDAQ NOVC 62 ZIOPHARM Oncology 62 Inc. OTCBB VYTR 62 Zavesca r 62 inhaled AAT 62 NYSE Amex RPC 62 evaluating picoplatin 62 Clinical Trial Results 62 ViroChem Pharma Inc. 62 Sinks Lower 62 Receives Complete Response 62 Bellicum Pharmaceuticals Inc. 62 Commence Phase 62 RECOTHROM ® 62 ® adefovir dipivoxil 62 Phase 2a clinical trials 62 Bellus Health 62 EGRIFTA TM 62 phase IIb III 62 Nasdaq BNVI 62 include Altastaph TM 62 Increlex TM 62 TKPHF 62 FDA Approvable Letter 62 mesylate tablets 62 Retisert ® 62 Neutrolin 62 R lenalidomide 62 palonosetron hydrochloride Injection Dacogen 62 NASDAQ DDSS 62 ECTE 62 Inc. NASDAQ ACOR 62 SWX BSLN 62 CD# CEA 62 Protalex Inc. 62 Omigard TM omiganan pentahydrochloride 62 ProEthic Pharmaceuticals 62 M Enoxaparin 62 lorvotuzumab mertansine 62 Files Shelf Registration Statement 62 NASDAQ CPEX 62 TOCOSOL Paclitaxel 62 candidates Azedra 62 Initiated Phase 62 submitted Biologics License 62 LE SN# 62 FavId 62 GNLB 62 Teikoku Pharma USA 62 Prestara 62 vinorelbine tartrate 62 evaluating intravenous picoplatin 62 SWISS BSLN 62 rusalatide acetate 62 Elagolix 62 VISICOL R 62 Vertex hepatitis C 62 Fero Industries Inc. 62 Silodosin 62 CCX# B 62 epoetin zeta 62 Immtech Pharmaceuticals Inc. 62 Tesetaxel 62 Neose Technologies 62 agonistic human 62 essential thrombocythemia ET 62 NASDAQ LGND 62 XIAFLEX ™ 62 Locteron ® 62 Corlux 62 Chaim Lebovits President 62 NovaBay Pharmaceuticals 62 Pivotal Phase 62 cladribine Cladribine Tablets 62 http:/www.generex.com 62 www.optimerpharma.com 62 generation purine nucleoside 62 Xeloda ® 62 Testosterone MDTS ® 62 Nasdaq RXII 62 Marketing Authorisation Application MAA 62 Femring ® 62 E2F Decoy 62 TSRX 62 PRNewswire FirstCall Labopharm 62 Dementia Related Psychosis 62 AMEX PTN 62 Inflazyme Pharmaceuticals 62 Biopharmaceuticals AG 62 Inc. NASDAQ ONTY 62 NASDAQ CRXL 62 Tech DVAX 62 palifosfamide Zymafos TM 62 Inc. Nasdaq SEPR 62 Exalgo TM 62 drug pipeline TAFA# 62 NASDAQ CXSP announced 62 Pimavanserin 62 POSIDUR TM ELADUR TM 62 GNSZ 62 Resubmission 62 3 registrational trial 62 MPH AMEX 62 UPLYSO 62 www.oxigene.com 62 AVANIR Pharmaceuticals 62 SinuNase 62 NASDAQ SHPGY 62 initiate Phase IIb 62 Somaxon Pharmaceuticals 62 SABER ™ 62 transdermal estradiol gel 62 OTCBB PVCT 62 OTCBB CHKT 62 NASDAQ NOVN